271 related articles for article (PubMed ID: 17160604)
1. Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know.
Hunfeld KP; Brade V
Wien Klin Wochenschr; 2006 Nov; 118(21-22):659-68. PubMed ID: 17160604
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy.
Hunfeld KP; Ruzic-Sabljic E; Norris DE; Kraiczy P; Strle F
Antimicrob Agents Chemother; 2005 Apr; 49(4):1294-301. PubMed ID: 15793100
[TBL] [Abstract][Full Text] [Related]
3. Lyme disease.
Berger BW
Semin Dermatol; 1993 Dec; 12(4):357-62. PubMed ID: 8312152
[TBL] [Abstract][Full Text] [Related]
4. The In Vitro Antimicrobial Susceptibility of
Hunfeld KP; Kraiczy P; Norris DE; Lohr B
Pathogens; 2023 Sep; 12(10):. PubMed ID: 37887720
[TBL] [Abstract][Full Text] [Related]
5. Risk of culture-confirmed borrelial persistence in patients treated for erythema migrans and possible mechanisms of resistance.
Hunfeld KP; Ruzić-Sabljić E; Norris DE; Kraiczy P; Strle F
Int J Med Microbiol; 2006 May; 296 Suppl 40():233-41. PubMed ID: 16530006
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Borrelia afzelii strains to antimicrobial agents.
Ruzić-Sabljić E; Podreka T; Maraspin V; Strle F
Int J Antimicrob Agents; 2005 Jun; 25(6):474-8. PubMed ID: 15871918
[TBL] [Abstract][Full Text] [Related]
7. Clinical and microbiologic findings in six patients with erythema migrans of Lyme disease.
Berger BW; Johnson RC
J Am Acad Dermatol; 1989 Dec; 21(6):1188-91. PubMed ID: 2511231
[TBL] [Abstract][Full Text] [Related]
8. Isolation of Borrelia burgdorferi sensu lato from blood of children with solitary erythema migrans.
Arnez M; Ruzić-Sabljić E; Ahcan J; Radsel-Medvescek A; Pleterski-Rigler D; Strle F
Pediatr Infect Dis J; 2001 Mar; 20(3):251-5. PubMed ID: 11303825
[TBL] [Abstract][Full Text] [Related]
9. Clinical and serological one-year follow-up of patients after the bite of Ixodes ricinus ticks infected with Borrelia burgdorferi sensu lato.
Briciu VT; Flonta M; Ţăţulescu DF; Meyer F; Sebah D; Cârstina D; Mihalca AD; Gherman CM; Hizo-Teufel C; Huber I; Fingerle V; Lupșe M
Infect Dis (Lond); 2017 Apr; 49(4):277-285. PubMed ID: 27866446
[TBL] [Abstract][Full Text] [Related]
10. Molecular and serological diagnosis of Borrelia burgdorferi infection among patients with diagnosed Erythema migrans.
Kondrusik M; Grygorczuk S; Skotarczak B; Wodecka B; Rymaszewska A; Pancewicz S; Zajkowska J; Swierzbińska R; Hermanowska-Szpakowicz T
Ann Agric Environ Med; 2007; 14(2):209-13. PubMed ID: 18247452
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.
Johnson RC; Kodner CB; Jurkovich PJ; Collins JJ
Antimicrob Agents Chemother; 1990 Nov; 34(11):2133-6. PubMed ID: 2073103
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Culture Positivity, PCR Positivity, and Burden of Borrelia burgdorferi Sensu Lato in Skin Samples of Erythema Migrans Patients with Clinical Findings.
Stupica D; Lusa L; Maraspin V; Bogovič P; Vidmar D; O'Rourke M; Traweger A; Livey I; Strle F
PLoS One; 2015; 10(9):e0136600. PubMed ID: 26352832
[TBL] [Abstract][Full Text] [Related]
13. [Clinical manifestations, diagnosis and treatment of Lyme borreliosis].
Ocias LF; Jensen BB; Knudtzen FC; Skarphedinsson S; Dessau RB
Ugeskr Laeger; 2017 May; 179(18):. PubMed ID: 28473022
[TBL] [Abstract][Full Text] [Related]
14. Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis.
Preac Mursic V; Marget W; Busch U; Pleterski Rigler D; Hagl S
Infection; 1996; 24(1):9-16. PubMed ID: 8852456
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of Borrelia burgdorferi strains isolated in the Czech Republic.
Janovská D; Hulínská D; Godová T
Cent Eur J Public Health; 2001 Feb; 9(1):38-40. PubMed ID: 11243589
[TBL] [Abstract][Full Text] [Related]
16. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
Lebech AM
APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
[TBL] [Abstract][Full Text] [Related]
17. Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents--possible implications for new therapeutic approaches to Lyme disease.
Hunfeld KP; Kraiczy P; Kekoukh E; Schäfer V; Brade V
Int J Med Microbiol; 2002 Jun; 291 Suppl 33():125-37. PubMed ID: 12141737
[TBL] [Abstract][Full Text] [Related]
18. Epidemiologic, ecologic and clinical characteristics of Lyme borrelliosis in northwest Croatia.
Golubić D; Rijpkema S; Tkalec-Makovec N; Ruzić E
Acta Med Croatica; 1998; 52(1):7-13. PubMed ID: 9599811
[TBL] [Abstract][Full Text] [Related]
19.
Koetsveld J; Draga ROP; Wagemakers A; Manger A; Oei A; Visser CE; Hovius JW
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674060
[TBL] [Abstract][Full Text] [Related]
20. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
